Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

GSK Plc and iTeos Therapeutics ended the development of an experimental lung cancer drug, the latest in a series of setbacks ...

Soon after giving birth to twins, Cornelia Tischmacher was diagnosed with lung cancer. It’s part of a trend of women, with no ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting for a possibly lifesaving procedure.

May 8, 2025 — A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve ...

Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

(Reuters) -iTeos Therapeutics and partner GSK said on Tuesday they have terminated development of their experimental lung ...

Soon after giving birth to twins, Cornelia Tischmacher was diagnosed with lung cancer. It’s part of a trend of women, with no ...